|
Device Problem
Activation, Positioning or Separation Problem (2906)
|
Patient Problem
Injury (2348)
|
Event Type
malfunction
|
Manufacturer Narrative
|
The physician in this case consented to participate in the survey but did not consent to be contacted regarding the information provided and wished to remain anonymous, therefore information for facility and city cannot be provided.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Medtronic conducted a post market clinical follow-up (pmcf) survey to seek out potential new risks and assess performance of the endeavor resolute rx coronary drug-eluting stent.Survey results from an interventional cardiologist in practice 13 years.In the past 12 months, the physician has used the endeavor resolute stent 90 times.10 of the smallest (2.25 x 8 mm), 60 intermediate (2.25 x 12 mm to 4.00 x 34 mm) and 20 of the largest sizes (4.00 x 38 mm) of these stents were used.The following device complaints were encountered in procedure when using the endeavor resolute product over the last 12 months: it was reported that the device did not perform as expected in terms of reaching the target lesion in 5 events due to the vessel being tortuous.It was also reported that in five cases the device did not perform as expected in terms of ability to achieve thrombolysis in myocardial infarction (timi) flow 3 due to the presence of too much calcification which needed to be dilated before again.
|
|
Search Alerts/Recalls
|
|
|